Assignee
YMMUNOBIO AG
CH·2 granted patents·1 pending application·0 citations·filing 2019–2023
Top patents by PatentIndex Score
3 records- 0172US12098205B2Therapeutic agent targeted to receptor protein, test agent, antibody that binds to receptor protein, and screening method for molecularly targeted drugsYMMUNOBIO AG·Filed 2023·Granted Sep 24, 2024·0 cites·7 claims
- 0256US11773169B2Therapeutic agent targeted to receptor protein, test agent, antibody that binds to receptor protein, and screening method for molecularly targeted drugsYMMUNOBIO AG·Filed 2019·Granted Oct 3, 2023·0 cites·6 claims
- 0342US2023295338A1A novel antibody binding specifically to human ceacam1/3/5 and use thereofYMMUNOBIO AG·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →